Stockreport

AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer [Yahoo! Finance]

AstraZeneca PLC - American Depositary Shares  (AZN) 
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF Enhertu (trastuzumab deruxtecan) is now approved in combination with Roche's Perjeta (pertuzumab) as first-line treatment for adult patients with unresectable or metasta [Read more]